Fisher & Paykel Healthcare Corporation Limited
FSPKF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.26 | -2.44 | -1.66 | -1.26 |
| FCF Yield | 2.55% | 0.60% | 0.19% | 1.14% |
| EV / EBITDA | 26.50 | 41.17 | 32.48 | 22.38 |
| Quality | ||||
| ROIC | -13.01% | 7.18% | 13.19% | 20.91% |
| Gross Margin | 41.41% | 60.28% | 59.54% | 61.70% |
| Cash Conversion Ratio | – | 3.24 | 0.95 | 0.86 |
| Growth | ||||
| Revenue 3-Year CAGR | -6.94% | 2.30% | -6.58% | 8.85% |
| Free Cash Flow Growth | 391.83% | 236.80% | -82.59% | -64.93% |
| Safety | ||||
| Net Debt / EBITDA | -0.17 | 0.29 | 0.06 | 0.02 |
| Interest Coverage | -33.42 | 13.98 | 49.96 | 103.90 |
| Efficiency | ||||
| Inventory Turnover | 2.19 | 2.18 | 1.76 | 1.75 |
| Cash Conversion Cycle | 227.95 | 203.91 | 233.53 | 215.80 |